Immix Biopharma Stock (NASDAQ: IMMX) stock price, news, charts, stock research, profile.
|Vol / Avg.118.856K / 230.990K||Mkt Cap96.394M|
|Day Range4.810 - 5.300||52 Wk Range1.010 - 5.470|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-08-14||Roth MKM||Jonathan Aschoff||Reiterates||BuyBuy||Maintains||-||14.00|
|2023-02-22||Roth MKM||Jonathan Aschoff||Initiates Coverage On||Buy||Announces||-||14.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Immix Biopharma (NASDAQ: IMMX) through any online brokerage.
The latest price target for Immix Biopharma (NASDAQ: IMMX) was reported by Roth MKM on Monday, August 14, 2023. The analyst firm set a price target for 14.00 expecting IMMX to rise to within 12 months (a possible 188.55% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Immix Biopharma (NASDAQ: IMMX) is $4.8519 last updated Today at November 29, 2023 at 3:08 PM UTC.
There is no dividend information for Immix Biopharma.
Immix Biopharma’s Q3 earnings are confirmed for Tuesday, December 12, 2023.
There is no upcoming split for Immix Biopharma.
Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.